First in class peptidomimetic drug for the treatment of TBI and sequelae nonclinical safety assessment
Ended Project Grant Awarded Last action
- Award ID
- HT94252310451
- Recipient
-
Alcamena Stem Cell Therapeutics, LLC UEI J6DAAQH7AQL8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,700,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Halethorpe, MD 21227, USA
Award details come from USAspending.gov.
Quick answers
Who received award HT94252310451?
HT94252310451 was awarded to Alcamena Stem Cell Therapeutics, LLC by Defense Health Agency (Department of Defense) on July 1, 2023.
How much is award HT94252310451 worth?
$1,700,000 has been obligated on HT94252310451.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award